Group | Subgroup | n | Coefficient (95% CI*) |
---|---|---|---|
Placebo | |||
GSTM/null | 29 | -1.01 (-1.80, -0.22) | |
GSTM/positive | 49 | -0.21 (-0.77, 0.35) | |
Genotype effect | 78 | 0.80 (-0.15, 1.75) | |
Supplement | |||
GSTM/null | 33 | -0.06 (-0.81, 0.69) | |
GSTM/positive | 47 | 0.10 (-0.60, 0.80) | |
Genotype effect | 80 | 0.16 (-0.88, 1.02) | |
GSTM/null | Placebo | 29 | -1.01 (-1.80, -0.22) |
Supplement | 33 | -0.06 (-0.81, 0.69) | |
Supplement effect | 62 | 0.95 (-0.14, 2.04) | |
GSTM/positive | Placebo | 49 | -0.21 (-0.77, 0.35) |
Supplement | 47 | 0.10 (-0.60, 0.80) | |
Supplement effect | 96 | 0.31 (-0.58, 1.21) | |
Simulation parameters: | |||
| |||
| |||
α7 = 0.95 ≈ 1 |